Patients with congenital heart disease now live well into adulthood because of advances in
surgical techniques, improvements in medical management, and the development of novel …

Background The past 3 decades have witnessed an exponential growth of transcatheter
interventions for congenital heart disease (CHD). Nowhere has this been more evident than …

Transcatheter therapy in children with congenital or acquired heart disease is a challenging,
innovative, and constantly evolving field. In this article we review the various “nonsurgical” …

The field of adult congenital interventions is unique in the world of cardiac catheterization,
combining the structural concepts commonly employed in pediatric heart disease and …

Cardiac catheterization in the adult patient with congenital heart disease clearly is now its
own field. The history of the field is closely tied to pediatric cardiac catheterization, in large …

As a result of improvements in surgical and interventional cardiac procedures, the majority of
children with congenital heart defects can now be expected to reach adulthood. Hence …

Adults with congenital heart disease (CHD) constitute a patient population that has grown
rapidly, due to advances in diagnosis and treatment of children with CHD. Though ideally …

Percutaneous therapies for congenital heart disease have evolved rapidly in the past 3
decades. This has occurred despite limited investment from industry and support from …

New developments in the transcatheter treatment of congenita... : Current Opinion in
Anesthesiology New developments in the transcatheter treatment of congenital heart …

Considerable progress has been made over the last decades in the diagnosis and treatment
of congenital heart disease (CHD) and over 90% of the children born with this condition are …